Sequence information
Variant position: 78 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: 122 The length of the canonical sequence.
Location on the sequence:
GNYDAAKRGPGGVWAAEAIS
D ARENIQRFFGHGAEDSLADQ
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human GNYDAAKRGPGGVWAAEAISD ARENIQRFFGHGAEDSLADQ
Mouse GNYDAAQRGPGGVWAAEKISD GREAFQEFFGRGHEDTIADQ
Rabbit GNYDAAQRGPGGVWAAKVISD AREDLQRLMGHGAEDSMADQ
Sequence annotation in neighborhood: The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:Type: the type of sequence feature. Positions: endpoints of the sequence feature. Description: contains additional information about the feature.
Type Positions Description
Chain
19 – 122
Serum amyloid A-1 protein
Chain
19 – 94
Amyloid protein A
Chain
20 – 122
Serum amyloid protein A(2-104)
Chain
20 – 121
Serum amyloid protein A(2-103)
Chain
20 – 120
Serum amyloid protein A(2-102)
Chain
21 – 122
Serum amyloid protein A(3-104)
Chain
22 – 119
Serum amyloid protein A(4-101)
Mutagenesis
65 – 65
R -> A. Reduces affinity for heparin; when associated with A-33 and A-37.
Mutagenesis
80 – 80
R -> A. Reduces affinity for heparin and nearly abolishes association with HDL; when associated with A-18 and A-89.
Mutagenesis
89 – 89
H -> A. Reduces affinity for heparin and nearly abolishes association with HDL; when associated with A-18 and A-80.
Helix
67 – 86
Literature citations
Heterogeneity of human serum amyloid A protein. Five different variants from one individual demonstrated by cDNA sequence analysis.
Steinkasserer A.; Weiss E.H.; Schwaeble W.; Linke R.P.;
Biochem. J. 268:187-193(1990)
Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 73-122; VARIANTS VAL-75 AND ASN-78;
Identification of two novel amyloid A protein subsets coexisting in an individual patient of AA-amyloidosis.
Baba S.; Takahashi T.; Kasama T.; Shirasawa H.;
Biochim. Biophys. Acta 1180:195-200(1992)
Cited for: PROTEIN SEQUENCE OF 19-94; MASS SPECTROMETRY; DISEASE; VARIANTS ALA-70; VAL-75 AND ASN-78; ALLELE SAA1.3;
Disclaimer:
Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.